TRANXENE CAP 15MG
TRANXENE CAP 15MG
Discontinued
DIN Number
00264911
Drug Class
Human
Market Date
Dec 31, 1973
Company
HC
ABBOTT LABORATORIES, LIMITED
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00264911
AIG Number0108895003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA05 CLORAZEPATE POTASSIUM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
CLORAZEPATE DIPOTASSIUMActive
Strength: 15 MG
Monograph: CLORAZEPATE DIPOTASSIUM